Elastosis perforans serpiginosa in a patient with pseudoxanthoma elasticum;Elastosis perforans serpiginosa en una enferma afecta de pseudoxantoma elástico

Actas Dermo-Sifiliograficas

Volumn 97, Issue 7, 2006, Pages 451-455

  Barnadas, M A ^a,b   Curell, R ^b   Pujol, R ^a   De Moragas, J M ^a   Alomar, A ^a  

^a Hospital Sant Pau I Santa Creu   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Altered elastic fibers; Granulomatous reaction; Transepidermal elimination

Indexed keywords

TAZAROTENE;

ADULT; ANAMNESIS; ARTICLE; BASOPHIL; CASE REPORT; CLINICAL FEATURE; ELASTOSIS; FEMALE; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; PSEUDOXANTHOMA ELASTICUM; TREATMENT DURATION;

EID: 33845457536     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(06)73439-1     Document Type: Article

References (24)

1. Whyte HJ, Winkelmann RK. Elastosis perforans (perforating elastosis). The association of congenital anomalies, salient facts in the histology, studies of enzyme digestion and a report of necropsy in a case. J Invest Dermatol. 1960;35:113-21.
2. Mehregan AH. Elastosis perforans serpiginosa. A review of the literature and report of 11 cases. Arch Dermatol. 1968;97:381-92.
3. Woo TY, Rasussen JE. Disorders of transepidermal elimination. Part 1. Int J Dermatol. 1985;24:267-79.
4. Patterson JW. The perforating disorders. J Am Acad Dermatol. 1984;10:561-81.
5. Ríos-Buceta L, Amigo-Echenagusía A, Sols-Candelas M, Fraga-Fernández J, Fernández-Herrera J. Elastosis perforans serpiginosa with simultaneous onset in two sisters. Int J Dermatol. 1993;32:879-81.
6. Uitto J. Biochemistry of the elastic fibers in normal connective tissues and its alterations in diseases. J Invest Dermatol. 1979;72:1-10.
7. Sherer DW, Sapadin AN, Lebwohl MG. Pseudoxanthoma elasticum: An update. Dermatology. 1999;199:3-7.
8. Uitto J. The gene family of ABC transporters - novel mutations, new phenotypes. Trends Mol Med. 2005;11:340-3.
9. Noji Y, Inazu A, Higashikata T, Nohara A, Kawashiri M, Yu W, et al. Identification of two novel missense mutations (p.R1221C and p.R1357W) in the ABCC6 (MRP6) gene in a japanese patient with pseudoxanthoma elasticum (PXE). Int Med. 2004;43:1171-6.
10. Pope FM. Historical evidence for the genetic heterogeneity of pseudoxanthoma elasticum. Br J Dermatol. 1975;92:493-509.
11. Sherer DW, Bercovitch L, Lebwohl M. Pseudoxanthoma elasticum: significance of limited phenotypic expression in parents of affected offspring. J Am Acad Dermatol. 2001;44:534-7.
12. Ayala F, Donofrio P. Elastosis perforans serpiginosa. Report of a family. Dermatológica. 1983;166:32-7.
13. Langeveld-Wildschut EG, Toonstra J, van Vloten WA, Beemer FA. Familial elastosis perforans serpiginosa. Arch Dermatol. 1993;129:205-7.
14. Fujimoto N, Tajima S, Ishibashi A. Elastin peptides induce migration and terminal differentiation of cultured keratinocytes via 67 kDa elastin receptor in vitro: 67 kDa elastin receptor is expressed in the keratinocytes eliminating elastic materials in elastosis perforans serpiginosa. J Invest Dermatol. 2000;115:633-9.
15. Schutt DA. Pseudoxanthoma elasticum and elastosis perforans serpiginosa. Arch Dermatol. 1965;91:151-2.
16. Caro I, Sher MA, Rippey JJ. Pseudoxanthoma elasticum and elastosis perforans serpiginosa. Dermatológica. 1975;150;36-42.
17. Lund HZ, Gilbert CF. Perforating pseudoxanthoma elasticum. Its distinction from elastosis perforans serpiginosa. Arch Pathol Lab Med. 1976;100:544-6.
18. Schwartz RA, Richfield DF. Pseudoxanthoma elasticum with transepidermal elimination. Arch Dermatol. 1978;114:279-80.
19. Hicks J, Carpenter CL, Reed RJ. Periumbilical perforating pseudoxanthoma elasticum. Arch Dermatol. 1979;115:300-3.
20. Smith EW, Malak JA, Goodman RM, McKusick VA. Reactive perforating elastosis: a feature of certain genetic disorders. Johns Hopkins Med J. 1962;111:235-55.
21. Heyl T. Pseudoxanthoma elasticum with granulomatous skin lesions. Arch Dermatol. 1967;96:528-31.
22. Woo TY, Rasmussen JE. Disorders of transepidermal elimination. Part 2. Int J Dermatol. 1985;24:337-48.
23. Outland JD, Brown TS, Callen JP. Tazarotene is an effective therapy for elastosis perforans serpiginosa. Arch Dermatol. 2002;138:169-71.
24. Ratnavel RC, Norrris PG. Penicillamine-induced elastosis perforans serpiginosa treated successfully with isotretinoin. Dermatology. 1994;189:81-3.